Comparison of Safety and Efficacy of Diazepam and Midazolam for Moderate Sedation during Gastric Endoscopic Submucosal Dissection
Digestive Diseases · 11.03.2025 · 43 (3) · 280-288
DOI: 10.1159/000545093 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Digestive Diseases, online erschienen am 11.03.2025. Verfasst von Jun Takada und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, Japan. Hauptthemen laut MEDLINE: Midazolam, Diazepam, Endoscopic Mucosal Resection, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
The appropriate use of benzodiazepines for sedation during prolonged therapeutic endoscopy has not yet been established. This retrospective observational study compared the safety and efficacy of diazepam (DZP) and midazolam (MDZ) under moderate sedation during gastric endoscopic submucosal dissection (ESD).
Methods
We studied 554 patients who underwent gastric ESD under sedation with DZP or MDZ combined with pentazocine. Sedation depth was assessed and recorded using the Richmond Agitation-Sedation Scale (RASS). According to the American Society of Anesthesiologists definition of sedation levels, RASS scores of −4 to −2 points indicated moderate sedation, whereas a score of −5 points indicated deep sedation. Sedation levels, respiratory and circulatory dynamics during the procedure, and the incidence of ESD-related pneumonia were compared.
Results
Of these, 273 and 281 patients received DZP and MDZ, respectively. No significant differences were observed in the occurrence of deep sedation (DZP:MDZ = 12.1%:15.4%) or in the proportion of patients who maintained moderate intraoperative sedation (76.2%:80.4%). Respiratory parameters showed no significant differences; however, blood pressure reduction was more common in the MDZ group (4.8%:11.0%, p = 0.007). Multivariate analysis identified MDZ as a significant factor associated with blood pressure reduction. The incidence of ESD-related pneumonia did not differ between the two groups.
Conclusions
DZP and MDZ were similarly effective in maintaining adequate sedation levels during gastric ESD. Respiratory depression did not differ between the groups; however, circulatory depression was more pronounced in the MDZ group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, Japan.
Zitieren
APA
Takada, J., Iwashita, T., Otani, K., Masuda, N., Taniguchi, H., Tezuka, Y., Arao, M., Kojima, K., Onishi, S., Kubota, M., Ibuka, T., & Shimizu, M. (2025). Comparison of Safety and Efficacy of Diazepam and Midazolam for Moderate Sedation during Gastric Endoscopic Submucosal Dissection. Digestive Diseases, 43(3), 280-288. https://doi.org/10.1159/000545093
Vancouver
Takada J, Iwashita T, Otani K, Masuda N, Taniguchi H, Tezuka Y, et al. Comparison of Safety and Efficacy of Diazepam and Midazolam for Moderate Sedation during Gastric Endoscopic Submucosal Dissection. Digestive Diseases. 2025;43(3):280-288. doi:10.1159/000545093
BibTeX
@article{Takada2025,
author = {Takada, Jun and Iwashita, Takuji and Otani, Kiichi and Masuda, Naoya and Taniguchi, Hiroki and Tezuka, Yukari and Arao, Masamichi and Kojima, Kentaro and Onishi, Sachiyo and Kubota, Masaya and Ibuka, Takashi and Shimizu, Masahito},
title = {Comparison of Safety and Efficacy of Diazepam and Midazolam for Moderate Sedation during Gastric Endoscopic Submucosal Dissection},
journal = {Digestive Diseases},
year = {2025},
volume = {43},
number = {3},
pages = {280--288},
doi = {10.1159/000545093}
}
EUVIMED